drugset / Trial / NCT02082769
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare febuxostat allopurinol in subjects with gout.
Timeline
- Start
- 2011-07
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | 100 mg | Oral |
| Subject | Febuxostat | Small molecule | 40 mg | Oral |
| Subject | Febuxostat | Small molecule | 80 mg | Oral |